Related Experiment Video

Updated: May 29, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

Molecular Mechanisms that Regulate Epidermal Growth Factor Receptor Inactivation

Brian P Ceresa1, Phillip A Vanlandingham

  • 1Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73190.

Clinical Medicine. Oncology
|September 6, 2011
PubMed

Insights

Epidermal Growth Factor Receptor (EGFR) signaling regulates cell functions but drives cancer when dysregulated. Understanding EGFR inactivation mechanisms is key to refining anti-cancer therapies targeting this receptor tyrosine kinase.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Epidermal Growth Factor Receptor (EGFR) is a receptor tyrosine kinase (RTK) crucial for normal cellular functions.
  • Dysregulated EGFR activity, through overexpression or hyperactivation, is implicated in various cancers.
  • EGFR's role in cancer is complex, potentially acting as both a cause and consequence of cell transformation.

Purpose of the Study:

  • To elucidate the molecular mechanisms governing EGFR inactivation.
  • To explore the therapeutic potential of targeting EGFR inactivation pathways for cancer treatment.
  • To refine current anti-EGFR therapies for broader efficacy in cancers with elevated EGFR activity.

Main Methods:

  • Review of molecular mechanisms regulating EGFR inactivation.
  • Analysis of signaling pathways involved in EGFR downregulation.
  • Discussion of therapeutic strategies targeting EGFR inactivation.

Main Results:

  • EGFR inactivation is a complex, multi-step process involving various molecular players.
  • Specific inactivation pathways present viable targets for therapeutic intervention.
  • Refining strategies to modulate EGFR inactivation can enhance anti-cancer therapy effectiveness.

Conclusions:

  • Targeting EGFR inactivation mechanisms offers a promising avenue for developing novel anti-cancer therapies.
  • Further research into EGFR inactivation is essential for overcoming resistance and improving treatment outcomes.
  • Modulating EGFR signaling through inactivation pathways could broaden the application of anti-EGFR therapies.
Keywords:
EGFRMVBdegradationendocytosis

More Related Videos

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy09:16

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy

Published on: September 11, 2015

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: